Stephen A Torrey, MD | |
500 Chase Pkwy, Suite 2a, Waterbury, CT 06708-3346 | |
(203) 755-6677 | |
(203) 755-7166 |
Full Name | Stephen A Torrey |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 500 Chase Pkwy, Waterbury, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609824218 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 027157 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephen A Torrey, MD 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708-3346 Ph: (203) 755-6677 | Stephen A Torrey, MD 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708-3346 Ph: (203) 755-6677 |
News Archive
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its U.S. joint venture with G-treeBNT, ReGenTree LLC, has completed enrollment of its Phase 2b/3 dry eye trial in the U.S.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Lumenis Ltd., and OpusDent Ltd., its dental laser division, announced the FDA clearance of the OpusDuoâ„¢ Er:YAG laser system for contact bone removal during oral surgical and periodontal procedures.
St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).
› Verified 1 days ago
Alan S. Waitze, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-573-1982 | |
Dr. Jarob N Mushaweh, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-755-7166 | |
Dr. David Forshaw, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Chase Pkwy, Waterbury, CT 06708 Phone: 203-755-6677 | |
Michael E. Karnasiewicz, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-573-9182 |